Moran Kevin Patrick 4
4 · Vanda Pharmaceuticals Inc. · Filed Aug 1, 2023
Insider Transaction Report
Form 4
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2023-07-28$6.30/sh−412$2,596→ 122,514 total - Sale
Common Stock
2023-07-28$6.30/sh−1,800$11,349→ 120,714 total
Holdings
- 635(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.